Statistics
Publications
6
Citations
737
H-Index
6
Active since
2015
Affiliations
Novo Nordisk (Denmark)(Current)
Rikke Bjerring Skyggebjerg is an author at Novo Nordisk (Denmark) specializing in pharmacology, pharmacy, and drug discovery.
Publications per year
2015–2024
6
6
Development of Cagrilintide, a Long-Acting Amylin Analogue
Thomas Kruse, Jakob Lerche Hansen, Kirsten Dahl et al. · Journal of Medicinal Chemistry · 2021 · 120 citations
Thomas Kruse, Rikke Bjerring Skyggebjerg, Henriette Kold Uldam et al. · Journal of Medicinal Chemistry · 2019 · 17 citations · Full text
1–5 of 6